Natural history of Epstein-Barr virus infection in a prospective pediatric cohort born to human immunodeficiency virus - Infected mothers

Journal of Infectious Diseases

Volumn 177, Issue 4, 1998, Pages 1087-1090

  Pedneault, Louise ^a   Lapointe, Normand ^b   Alfieri, Caroline ^b   Ghadirian, Parviz ^b   Carpentier, Linda ^b   Samson, Johanne ^b   Joncas, Jean ^b  

^a GLAXOSMITHKLINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; EPSTEIN BARR VIRUS; FEMALE; HEPATOMEGALY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTIOUS MONONUCLEOSIS; MAJOR CLINICAL STUDY; MALE; MATERNAL DISEASE; NEWBORN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROCONVERSION; SPLENOMEGALY; VIRUS INFECTIVITY; VIRUS REPLICATION;

EID: 0031978050     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517401     Document Type: Article

References (15)

1. Laurence J, Astrin SM. Human immunodeficiency virus induction of malignant transformation in human B lymphocytes. Proc Natl Acad Sci USA 1991;88:7635-9.
2. Mallon R, Borkowski J, Albin R, Pepitoni S, Schwartz J, Kieff E. The Epstein-Barr virus BZLF1 gene product activates the human immunodeficiency virus type 1 5′ long terminal repeat. J Virol 1990;64:6282-5.
3. Birx DL, Redfield RR, Tosato G. Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders. N Engl J Med 1986;314:874-9.
4. Sumaya CV, Boswell RN, Ench Y, et al. Enhanced serological and virological findings of Epstein-Barr virus in patients with AIDS and AIDS-related complex. J Infect Dis 1986;154:864-70.
5. Greenspan D, Greenspan JS. Significance of oral hairy leukoplakia. Oral Surg Oral Med Oral Pathol 1992;73:151-4.
6. Andiman WA, Eastman R, Martin K, et al. Opportunistic lymphoproliferations associated with Epstein-Barr viral DNA in infants and children with AIDS. Lancet 1985;2:1390-3.
7. MacMahon EME, Glass JD, Hayward SD, et al. Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet 1991;338:969-73.
8. McClain KL, Leach CT, Jenson HB, et al. Association of Epstein-Barr virus with leiomyosarcomas in young people with AIDS. N Engl J Med 1995;332:12-8.
9. Centers for Disease Control and Prevention. 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Morb Mortal Wkly Rep 1994;43:1-10.
10. Henle G, Henle W. Immunofluorescence in cells derived from Burkitt's lymphoma. J Bacteriol 1966;91:1248-56.
11. Henle W, Henle G, Niederman JC, Klemola E, Haltia K. Antibodies to early antigens induced by Epstein-Barr virus in infectious mononucleosis. J Infect Dis 1971;124:58-67.
12. Pedneault L, Lapointe N, Alfieri C, et al. Antibody responses to two Epstein-Barr virus (EBV) nuclear antigens (EBNA-1 and EBNA-2) during EBV primary infection in children born to mothers infected with human immunodeficiency virus. Clin Infect Dis 1996;23:806-8.
13. Savoie A, Perpête C, Carpentier L, Joncas J, Alfieri C. Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease. Blood 1994;83:2715-22.
14. Ho M, Miller G, Atchison RW, et al. Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection. J Infect Dis 1985;152:876-86.
15. Sumaya CV. Epstein-Barr virus infections in children. Curr Probl Pediatr 1987;17:677-722.